(Q39390327)

English

Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

0 references

Japanese encephalitis virus

0 references

Japanese encephalitis

1 reference

based on heuristic

inferred from title

Suvaporn Anugulruengkitt

object named as

Suvaporn Anugulruengkitt

3

0 references

7

object named as

Sutee Yoksan

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

author name string

Pakpoom Janewongwirot

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Thanyawee Puthanakit

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Watsamon Jantarabenjakul

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Chayapa Phasomsap

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sompong Chumket

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Chitsanu Pancharoen

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

0 references

publication date

12 September 2016

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

5279-5283

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Estimated global incidence of Japanese encephalitis: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.005

7 January 2021

Protection against Japanese encephalitis by inactivated vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.005

7 January 2021

Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.005

7 January 2021

Adverse reactions to Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.005

7 January 2021

Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.005

7 January 2021

High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.005

7 January 2021

Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.005

7 January 2021

Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months: randomized, controlled phase 3 immunogenicity and safety trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.005

7 January 2021

Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.005

7 January 2021

Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.005

7 January 2021

Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine: randomized, double-blind, 5-year phase II study in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.005

7 January 2021

Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.005

7 January 2021

Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.005

7 January 2021

Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.09.005

7 January 2021

Identifiers

10.1016/J.VACCINE.2016.09.005

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39390327&oldid=1824627636"